These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10171 related articles for article (PubMed ID: 1505600)

  • 1. Adriamycin combined with hyperthermia and dipyridamole is cytotoxic both in vitro and in vivo.
    Sakaguchi Y; Maehara Y; Emi Y; Kohnoe S; Sugimachi K
    Eur Surg Res; 1992; 24(4):249-56. PubMed ID: 1505600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole.
    Maehara Y; Sakaguchi Y; Takahashi I; Yoshida M; Kusumoto H; Masuda H; Sugimachi K
    Cancer Chemother Pharmacol; 1992; 29(4):257-60. PubMed ID: 1537070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment of adriamycin and dipyridamole inhibits lung metastasis of B16 melanoma cells in mice.
    Sakaguchi Y; Emi Y; Maehara Y; Kohnoe S; Sugimachi K
    Eur Surg Res; 1990; 22(4):213-8. PubMed ID: 2265656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole potentiates adriamycin cytotoxicity by a mechanism other than inhibiting nucleoside uptake.
    Kusumoto H; Maehara Y; Anai H; Kumashiro R; Sugimachi K
    Anticancer Res; 1991; 11(4):1539-42. PubMed ID: 1746911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipyridamole augments the antitumor effects of fluorinated pyrimidines.
    Sakaguchi Y; Kusumoto T; Kusumoto H; Maehara Y; Furusawa M; Sugimachi K
    Anticancer Res; 1992; 12(1):119-21. PubMed ID: 1567156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of adriamycin cytotoxicity by dipyridamole against HeLa cells in vitro and sarcoma 180 cells in vivo.
    Kusumoto H; Maehara Y; Anai H; Kusumoto T; Sugimachi K
    Cancer Res; 1988 Mar; 48(5):1208-12. PubMed ID: 3342401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoacting agents flavone acetic acid and hydralazine given in combination enhance antitumor effects under condition of hyperthermia.
    Yamamoto M; Kusumoto T; Endo K; Baba H; Sakaguchi Y; Maehara Y; Sugimachi K
    Oncology; 1996; 53(2):147-52. PubMed ID: 8604241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole combination chemotherapy can be used safely in treating gastric cancer patients.
    Sakaguchi Y; Maehara Y; Emi Y; Kusumoto T; Kohnoe S; Sugimachi K
    Anticancer Drugs; 1991 Apr; 2(2):139-43. PubMed ID: 1958858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia.
    Takeuchi H; Baba H; Maehara Y; Sugimachi K; Newman RA
    Cancer Chemother Pharmacol; 1996; 38(1):1-8. PubMed ID: 8603441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole.
    Desai PB; Duan J; Sridhar R; Damle BD
    Methods Find Exp Clin Pharmacol; 1997 May; 19(4):231-9. PubMed ID: 9228648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fundamental study on hyperthermic chemotherapy using adriamycin-loaded hydroxyapatite].
    Nakatani S; Kunieda K; Seki T; Wakabayashi M; Inoue K; Nagata K; Murata T; Tanaka Y; Sougawa M; Kimura R
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1644-7. PubMed ID: 1326924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic and survival response of the M14 cell line to lonidamine associated with adriamycin or hyperthermia.
    Starace G; Badaracco G; Bertuzzi A; Gandolfi A; Greco C; Totaro MD; Vitelli R; Zupi G
    J Cancer Res Clin Oncol; 1987; 113(5):451-8. PubMed ID: 3624301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavone acetic acid increases the antitumor effect of hyperthermia in mice.
    Sakaguchi Y; Maehara Y; Baba H; Kusumoto T; Sugimachi K; Newman RA
    Cancer Res; 1992 Jun; 52(12):3306-9. PubMed ID: 1596889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipyridamole combined with tumor necrosis factor-alpha enhances inhibition of proliferation in human tumor cell lines.
    Suzuki N; Sekiya S; Sugano I; Kojima T; Yamamori H; Takakubo Y
    Jpn J Cancer Res; 1995 Aug; 86(8):761-9. PubMed ID: 7559100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of interleukin-2 activated killer cells against adriamycin resistant mouse B16-BL6 melanoma.
    Gautam SC; Chikkala NF; Lewis I; Grabowski DR; Finke JH; Ganapathi R
    Anticancer Res; 1992; 12(3):921-5. PubMed ID: 1622150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines.
    Nakanishi O; Baba M; Saito A; Yamashita T; Sato W; Abe H; Fukazawa N; Suzuki T; Sato S; Naito M; Tsuruo T
    Oncol Res; 1997; 9(2):61-9. PubMed ID: 9167187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of thermosensitivity and chemosensitivity induced by combined treatments with hyperthermia and adriamycin.
    Hayashi S; Kano E; Tsuji K; Furukawa-Furuya M; Yoshikawa S; Hatashita M; Matsumoto H; Jin ZH; Ohtsubo T; Kitai R
    Int J Mol Med; 2001 Oct; 8(4):417-22. PubMed ID: 11562781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of 5-fluorouracil cytotoxicity by combining hyperthermia and dipyridamole in vitro.
    Maehara Y; Sakaguchi Y; Kusumoto T; Kusumoto H; Sugimachi K
    Anticancer Res; 1989; 9(4):967-9. PubMed ID: 2817823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal scheduling increases therapeutic gain of adriamycin combined with hyperthermia.
    Baba H; Maehara Y; Takeuchi H; Inutsuka S; Sugimachi K
    Anticancer Res; 1993; 13(3):651-4. PubMed ID: 8317893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MST-16, a novel derivative of bis(2,6-dioxopiperazine), synergistically enhances the antitumor effects of anthracyclines.
    Inutsuka S; Baba H; Maehara Y; Sugimachi K
    Cancer Chemother Pharmacol; 1998; 42(3):194-200. PubMed ID: 9685054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 509.